SWOG S1925

Primary Category:

Treatment Protocols

Disease Category:

Chronic Lymphocytic Leukemia, Lymphoma

Status:

New, Open

Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

Eligible for screening study DCP 001

NCT#04269902